To satisfy House Democrats, the Trump administration removed a provision that would have given the makers of ultra-expensive biologic drugs 10 years of protection from less-expensive knockoffs.
By Paul Wiseman, Kevin Freking, Associated Press, Linda A. Johnson, Associated PRess
Over the past two decades, hundreds of thousands of Americans have died during a national opioid addiction crisis. As the drug manufacturers face a possible legal reckoning from multiple lawsuits, a newly uncovered database sheds more light on the scope…
If Republicans prevail in just two races on Tuesday, the Senate’s ranks would suddenly include two former drug industry lobbyists and a pharma CEO.
By Lev Facher, STAT
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.